Clinical Trial Update: Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study of GSK3901961 in previously treated synovial sarcoma, myxoid/round cell liposarcoma, and metastatic non-small cell lung cancer was terminated, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myxoid Round Cell Liposarcoma
• Non-small Cell Lung Cancer
• Synovial Sarcoma

Drugs mentioned

• GSK3901961

Snippet

Sponsor: Adaptimmune | Conditions: Neoplasms | Phase 1 | Status: TERMINATED | Results posted: 2024-05-10